🇺🇸 FDA
Patent

US 9782357

RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules

granted A61KA61K31/7105A61K31/713

Quick answer

US patent 9782357 (RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules) held by The Regents of the University of California expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/7105, A61K31/713, A61K47/14, A61K47/18